Leila Alland
Director/Board Member at ABEONA THERAPEUTICS INC.
Net worth: 342 818 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Amoroso | M | 46 | 4 years | |
| Vishwas Seshadri | M | 48 | 3 years | |
| Syed M. J. Kazmi | M | 67 |
Jubilant Therapeutics, Inc.
 Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ. | - |
| Christine Silverstein | F | 41 | 8 years | |
| Joseph Vazzano | M | 40 | 2 years | |
| Amanda Moore | F | - | 4 years | |
| Hester Larkin | F | - | 2 years | |
| Ian Turner | M | - | - | |
| Riccardo Canevari | M | - | 3 years | |
| Donald Wuchterl | M | 54 | 3 years | |
| Mark Alvino | M | 56 | 3 years | |
| Brendan OMalley | M | 55 | 5 years | |
| Greg Gin | M | - | 4 years | |
| Nadir Patel | M | 54 |
Jubilant Therapeutics, Inc.
Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ. | 1 years |
| Thomas Tulip | M | 71 | 3 years | |
| Faith Charles | F | 62 | 3 years | |
| Hari Shankar Bhartia | M | 67 |
Jubilant Therapeutics, Inc.
Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ. | - |
| Robert Glassman | M | 62 |
Jubilant Therapeutics, Inc.
Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ. | 3 years |
| Vittorio Puppo | M | - | 2 years | |
| Sherin Al-Safadi | M | - | 1 years | |
| Nathan Jong | M | - | - | |
| Madhav Vasanthavada | M | - | - | |
| Alison Hardgrove | F | - | 2 years | |
| Mathieu Simon | M | 68 | 6 years | |
| Levente Meszaros | M | - | 2 years | |
| Gitasha Chand | M | - | 2 years | |
| David Mozley | M | - | - | |
| Mitch Guss | M | - |
Jubilant Therapeutics, Inc.
Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ. | - |
| Paul Hopper | M | 68 | 3 years | |
| Scot Harper | M | 67 | 3 years | |
| Carl Denny | M | - | 3 years | |
| Brian Kevany | M | - | 6 years | |
| Igor Grachev | M | 63 | 3 years | |
| Pramod Yadav | M | 60 |
Jubilant Therapeutics, Inc.
Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ. | - |
| Antje Wegener | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brian Roberts | M | 53 |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | - |
| Jodie Gillon | F | - | 2 years | |
| Steve H. Rouhandeh | M | 67 | 13 years | |
| Gregory W. Gin | M | - | - | |
| Tony Fiorino | M | 56 |
Albert Einstein College of Medicine, Inc.
| 4 years |
| Michael Baker | M | - | 3 years | |
| Adrien Lemoine | M | - |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | 1 years |
| Giuseppe Ciaramella | M | 55 |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | 3 years |
| Wendy Dwyer | F | 50 |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | 3 years |
| Sheng Yao | M | 49 |
Albert Einstein College of Medicine, Inc.
| 3 years |
| Hui Feng | M | 48 |
Albert Einstein College of Medicine, Inc.
| 3 years |
| NgocDiep Le | M | 56 |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | 2 years |
| William Ludlam | M | 59 |
Albert Einstein College of Medicine, Inc.
| 3 years |
| Harry Fisch | M | 65 |
Albert Einstein College of Medicine, Inc.
| 1 years |
| Sharon Solomon | F | - |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | 2 years |
| J. Ware | M | 71 |
Albert Einstein College of Medicine, Inc.
| 5 years |
| Richard Daly | M | 62 |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | 1 years |
| Rachel Humphrey | M | 62 |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | 1 years |
| Martin Treder | M | - | 4 years | |
| Peter Honig | M | 67 |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | 4 years |
| Michael Metzger | M | 53 |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | - |
| David Ferreiro | M | - |
Albert Einstein College of Medicine, Inc.
| 6 years |
| Scott Nogi | M | - | 4 years | |
| Peter Hutt | M | 89 |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | 5 years |
| Jan Geliebter | M | 65 |
Albert Einstein College of Medicine, Inc.
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 43 | 71.67% |
| Australia | 14 | 23.33% |
| Germany | 3 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Leila Alland
- Personal Network
